Search Results - "Brachman, D"

The Feasibility of Dose Escalation With Simultaneous Integrated Boost (SIB) Technique in Patients With Large Functioning Pituitary Macroadenomas Treated With Robotic Radiosurgery by Pinnaduwage, D, Welch, G.D, Youssef, E, Srivastava, S, Brachman, D

Get full text

A Mutation and Prognostic Biomarker Study in Grade II and III Gliomas Utilizing a Combined Cohort of NRG Oncology/RTOG 9802 and 9813 by Bell, E.H, McElroy, J.P, Fleming, J, Timmers, C, Chakraborty, A.R, Salavaggione, A.L, Chang, S.M, Shaw, E.G, Aldape, K, Brachman, D, Schultz, C.J, Shih, H.A, Curtis, M, Hunter, G.K, Murtha, A.D, Zhang, P, Won, M, Mehta, M.P, Chakravarti, A

Get full text

Treatment Responses and Survival in IDH1-Mutant Grade II and III Gliomas in NRG Oncology/RTOG 9802 and 9813 by Bell, E.H, Zhang, P, Buckner, J.C, Chang, S.M, Salavaggione, A.L, Brachman, D, Lee, R.J, Murtha, A.D, Brown, P.D, Schultz, C.J, Malone, S, Mehta, M.P, Pugh, S.L, Chakravarti, A

Get full text

Intermediate-Risk Meningioma: Initial Outcomes from NRG Oncology/RTOG-0539 by Rogers, L, Zhang, P, Vogelbaum, M.A, Perry, A, Ashby, L, Modi, J, Alleman, A, Galvin, J.M, Brachman, D, Jenrette, J.M, DeGroot, J, Bovi, J.A, Werner-Wasik, M, Knisely, J.P.S, Mehta, M.P

Get full text

Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients: results from a single practice by Brachman, D G, Thomas, T, Hilbe, J, Beyer, D C

“…To evaluate failure-free survival (FFS) for brachytherapy (BT) alone compared to external beam radiotherapy (EBRT) alone for Stage T1-2 Nx-No Mo patients over…”
Get more information

IDH Status Predicts Benefit From PCV With Radiation Therapy in Anaplastic Oligodendroglioma (RTOG 9402) by Cairncross, G, Wang, M, Jenkins, R, Shaw, E, Giannini, C, Brachman, D, Buckner, J, Fink, K, Mehta, M, Curran, W

Get full text

Stereotactic Radiosurgery for Stage I NSCLC in Medically Inoperable Patients: A Prospective Multicenter Phase II Study by Pennathur, A, Loo, B.W, Heron, D.E, Whyte, R.I, Zajac, A, Brachman, D, Gooding, W.E, Christie, N.A, Urschel, H.C, Luketich, J.D

Get full text

p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines by BRACHMAN, D. G, BECKETT, M, GRAVES, D, HARAF, D, VOKES, E, WEICHSELBAUM, R. R

“…The molecular basis of tumor response to therapeutic radiation is poorly understood. Recent evidence suggests the p53 tumor suppressor gene may be involved in…”
Get full text

Determinants of Therapeutic Resistance in Glioblastomas: Lessons Learned from RTOG 0211 and Beyond by Chakravarti, A, Wang, M, Robins, H, Guha, A, Curren, W, Brachman, D, Choucair, A, Dolled-Filhart, M, Lautenschlaeger, T, Mehta, M

Get full text

Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival by HARAF, D. J, NODZENSKI, E, BRACHMAN, D, MICK, R, MONTAG, A, GRAVES, E, VOKES, E. E, WEICHSELBAUM, R. R

“…Recent studies have shown that p53 mutations are frequently found in cancer of the head and neck, whereas others have indicated that human papilloma virus…”
Get full text

Final report of Radiation Therapy Oncology Group (RTOG) protocol 9802: Radiation therapy (RT) versus RT + procarbazine, CCNU, and vincristine (PCV) chemotherapy for adult low-grade glioma (LGG) by Shaw, E. G., Wang, M., Coons, S., Brachman, D., Buckner, J. C., Stelzer, K., Barger, G., Brown, P. D., Gilbert, M. R., Mehta, M. P.

“…Abstract only…”
Get full text

Molecular biology of head and neck cancer by Brachman, D G

Get more information

Resection and Surgically Targeted Brain Brachytherapy Without and With Systemic Therapy for Locally Recurrent GBM by Nakaji, P., Brachman, D., Smith, K., Thomas, T., Dardis, C., Pinnaduwage, D., Wallstrom, G., Rogers, C.L., Youssef, E.F.

“…Recurrent GBM (rGBM) is a diffuse disease, and local treatment alone does not provide durable local control (LC) or prolong overall survival (OS)…”
Get full text

Failure free survival following brachytherapy alone for prostate cancer: comparison with external beam radiotherapy by Beyer, David C, Brachman, David G

“…Background and purpose: To compare failure free survival (FFS) for brachytherapy (BT) alone and external beam radiotherapy (EBXRT) alone. Materials and…”
Get full text

Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer by Brachman, D G, Graves, D, Vokes, E, Beckett, M, Haraf, D, Montag, A, Dunphy, E, Mick, R, Yandell, D, Weichselbaum, R R

“…Little is known regarding the molecular genetic events in head and neck carcinoma. Epidemiological evidence suggests that both alcohol and tobacco use are…”
Get full text

P03.15.B SURGICALLY TARGETED RADIATION THERAPY (START) FOR RECURRENT GLIOBLASTOMA: INITIAL OUTCOMES FROM A PROSPECTIVE MULTICENTER REGISTRY by Ozair, A, Shen, C, Lee, S, Pham, H, Chamoun, R, Choutka, O, Hanft, S, Shah, M, Richardson, A, DiNapoli, V, Wardak, Z, Ferreira, C, Khosla, A A, Bojanowski-Hoang, K, Mercado, C E, Ryan, R, Wasilewski, A, Brachman, D, Campbell, L, Chen, C, Dusenbery, K, Floyd, J, Patel, T, Hayden, D, Nowlan, A, McCracken, D, Wanebo, J, Ranjan, T, Rodriguez, A, Patel, A J, Camarata, P J, Kotecha, R R, McDermott, M W, Ahluwalia, M S

“…Abstract BACKGROUND Surgically targeted radiation therapy (STaRT), using a novel bioresorbable collagen brachytherapy device containing 4 Cesium-131 sources,…”
Get full text

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol by Souhami, Luis, Seiferheld, Wendy, Brachman, David, Podgorsak, Ervin B, Werner-Wasik, Maria, Lustig, Robert, Schultz, Christopher J, Sause, William, Okunieff, Paul, Buckner, Jan, Zamorano, Lucia, Mehta, Minesh P, Curran, Jr, Walter J

“…Conventional treatment of glioblastoma multiforme (GBM) cures less than 5% of patients. We investigated the effect of stereotactic radiosurgery (SRS) added to…”
Get more information

Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes by Rubin, S J, Hallahan, D E, Ashman, C R, Brachman, D G, Beckett, M A, Virudachalam, S, Yandell, D W, Weichselbaum, R R

“…Two prostate carcinoma cell lines, DU-145 and PC-3, were examined for abnormalities in the retinoblastoma (Rb) and the p53 putative tumor suppressor genes. We…”
Get more information

p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas by BRACHMAN, HALLAHAN, D. E, BECKETT, M. A, YANDELL, D. W, WEICHSELBAUM, R. R

“…The potentially carcinogenic effect of therapeutic irradiation has been recognized for many years. Second malignancies, usually sarcomas, are known to arise…”
Get full text

AT-10 SURGERY (S) AND PERMANENT INTRAOPERATIVE BRACHYTHERAPY (BT) IMPROVES TIME TO PROGRESSION OF RECURRENT INTRACRANIAL NEOPLASMS: A REPORT OF 27 CASES USING A MODULAR, BIOCOMPATIBLE CARRIER AND REAL-TIME DOSIMETRIC PLANNING by Brachman, D., Nakaji, P., Dardis, C., Sorensen, S., Thomas, T., Smith, K., Sanai, N., Youssef, E., McBride, H.

“…BACKGROUND: We report our experience using surgery (S) and permanent brachytherapy (BT) implants in the treatment of 27 separate recurrent/progressive…”
Get full text